217 related articles for article (PubMed ID: 23759931)
21. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
[TBL] [Abstract][Full Text] [Related]
22. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
24. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
[TBL] [Abstract][Full Text] [Related]
25. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
27. Gastric collision tumor of large cell neuroendocrine carcinoma and adenocarcinoma--a case report.
Jang KY; Moon WS; Lee H; Kim CY; Park HS
Pathol Res Pract; 2010 Jun; 206(6):387-90. PubMed ID: 19945227
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors.
Bartley AN; Rashid A; Fournier KF; Abraham SC
Hum Pathol; 2011 Oct; 42(10):1420-9. PubMed ID: 21419473
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A expression correlates with tumour cell type and prognosis in signet ring cell carcinoma of the stomach.
Fujiyoshi Y; Eimoto T
Histopathology; 2008 Feb; 52(3):305-13. PubMed ID: 18269581
[TBL] [Abstract][Full Text] [Related]
30. Exocrine and endocrine modulation in common gastric carcinoma.
Canzonieri V; Colarossi C; Del Col L; Perin T; Talamini R; Sigon R; Cannizzaro R; Aiello E; Buonadonna A; Italia F; Massi D; Carbone A; Memeo L
Am J Clin Pathol; 2012 May; 137(5):712-21. PubMed ID: 22523208
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
35. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma.
Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z
Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390
[TBL] [Abstract][Full Text] [Related]
36. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma.
Michelassi F; Takanishi DM; Pantalone D; Hart J; Chappell R; Block GE
Surgery; 1994 Oct; 116(4):804-9; discussion 809-10. PubMed ID: 7940182
[TBL] [Abstract][Full Text] [Related]
37. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
38. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
39. [Primary superficial small cell neuroendocrine carcinoma of esophagus: clinicopathologic and immunohistochemical analysis of 15 cases].
Lu J; Lü N; Xue LY; Zou SM; Liu XY; Wen P
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):736-40. PubMed ID: 22336155
[TBL] [Abstract][Full Text] [Related]
40. A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma; an immunohistochemical and ultrastructural study.
Yamazaki K
Virchows Arch; 2003 Jan; 442(1):77-81. PubMed ID: 12536318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]